How to Calculate Your Triglyceride to HDL Ratio

Learn how to calculate your triglyceride to HDL ratio, what your result means for heart health, and practical ways to improve it.

To calculate your triglyceride-to-HDL ratio, divide your triglyceride level by your HDL cholesterol level. If your lab report shows triglycerides of 150 mg/dL and HDL cholesterol of 50 mg/dL, your ratio is 3.0. The catch is that the number you get depends on whether your lab reports lipids in mg/dL (standard in the United States) or mmol/L (common in much of the rest of the world), and the thresholds for concern differ by sex and ethnic background in ways that a single “ideal” number cannot capture.

The Math and Where to Find Your Numbers

Your standard lipid panel blood test includes everything you need. Look for two values: triglycerides (sometimes abbreviated TG or TRIG) and HDL cholesterol (sometimes labeled HDL-C). The formula is simply triglycerides divided by HDL cholesterol. Both numbers must be in the same units for the result to mean anything.

If your results are in mg/dL, which is what most American labs use, a person with triglycerides of 120 and HDL of 60 has a ratio of 2.0. If your results are in mmol/L, the same metabolic profile would give a ratio of about 0.9, because the conversion factors for triglycerides and HDL cholesterol differ. One study explicitly noted that a ratio above 2.0 in mg/dL corresponds to about 0.9 in mmol/L, and both cutoffs identified the same shift toward smaller, denser LDL particles. To convert a mg/dL ratio to a mmol/L ratio, multiply by roughly 0.44. To go the other direction, multiply your mmol/L ratio by about 2.3.

One practical note on timing: triglycerides rise after eating and can stay elevated for several hours. In a large population study, triglyceride levels climbed by as much as 0.3 mmol/L (roughly 27 mg/dL) in the hours after a normal meal, while HDL cholesterol barely moved. That means a non-fasting blood draw can inflate your ratio. If your ratio looks high and you ate beforehand, ask your doctor whether it is worth repeating after an overnight fast.

Why This Ratio Matters

A standard lipid panel gives you total cholesterol, LDL, HDL, and triglycerides as separate numbers. Each has value, but the triglyceride-to-HDL ratio captures something the individual numbers miss: it reflects how your body handles insulin and what type of LDL particles you tend to produce. Those two things together tell a sharper story about metabolic and cardiovascular risk than any single lipid value on its own.

When the ratio is high, it tends to track with insulin resistance, the metabolic state where your cells respond poorly to insulin and your pancreas has to pump out more to keep blood sugar in check. The ratio was originally proposed as a convenient stand-in for insulin resistance because triglycerides and HDL cholesterol are already part of routine blood work, while directly measuring insulin sensitivity requires more expensive tests. Multiple studies have since confirmed the connection. In one study of non-diabetic adults, a cutoff of 1.73 identified insulin resistance with sensitivity above 76% and specificity above 81%.

The ratio also tracks with LDL particle size. Not all LDL cholesterol is the same. Small, dense LDL particles are considered more harmful because they penetrate artery walls more easily and are more prone to oxidation. When your triglyceride-to-HDL ratio is elevated, you are more likely to carry the small, dense pattern of LDL. Research in Asian Indian populations confirmed the same relationship: as the ratio climbed, LDL particles got smaller and more numerous.

Those two mechanisms, insulin resistance and small dense LDL, feed into bigger cardiovascular risk. In a study of patients who underwent coronary angiography, the ratio outperformed individual lipid values at predicting who had extensive coronary disease. The odds of having widespread blockage roughly doubled in patients with an elevated ratio compared to those with a low one. Another study in patients with stable angina found that those in the highest quarter of TG/HDL-C ratios had nearly three times the risk of coronary events compared to those in the lowest quarter, and this held up even after accounting for LDL cholesterol and medications. Over longer follow-up, the ratio predicted heart disease death and new-onset type 2 diabetes in men independently of other standard risk factors.

General Benchmarks and Why a Single Cutoff Does Not Work

You will find plenty of websites quoting neat cutoffs like “below 2.0 is ideal” or “above 4.0 is dangerous.” The research is more nuanced than that. Cutoffs for the ratio vary depending on what outcome you are trying to predict (insulin resistance versus heart disease versus fatty liver), what population was studied, and which units are being used. Still, some rough guideposts help.

For adults using mg/dL, a ratio below about 2.0 is generally associated with a favorable LDL particle pattern and lower insulin resistance. Between 2.0 and roughly 4.0 sits a gray zone that depends on your sex and background. Above 4.0, most studies agree that metabolic risk is clearly elevated. One analysis of young adults found that cardiometabolic risk factors were substantially worse in men whose ratio exceeded 3.5 and women whose ratio exceeded 2.5. At those thresholds, about a third of participants were classified as insulin resistant.

The sex gap is consistent across studies. Women tend to have higher HDL cholesterol and lower triglycerides than men, which pushes their ratio lower at baseline. A mixed-population study from Brazil proposed sex-specific cutoffs of 2.6 for men and 1.7 for women to flag cardiometabolic disease, and noted that these held up across different ethnic groups within their sample. A study of Han Chinese adults found even lower optimal cutoffs for women: around 0.9 to 1.1 in mmol/L units (roughly 2.0 to 2.5 in mg/dL) versus 1.3 to 1.4 in men (about 3.0 to 3.2 in mg/dL). The bottom line: applying a single cutoff to both sexes will miss risk in women and overcount it in men.

Ethnicity and Age Change the Picture

This is where the ratio’s limitations get real. The association between the TG/HDL-C ratio and insulin resistance is strongest in White European populations. In a study of obese youth, the ratio reliably identified insulin-resistant White children and adolescents, but the relationship fell apart in Hispanic and African American youth, to the point that researchers could not even calculate a meaningful cutoff for those groups. This does not mean the ratio is useless in non-White populations, but it does mean that the commonly quoted thresholds may miss the mark.

South Asian populations present a mixed story. In one study that directly compared White European and South Asian adults, the ratio correlated well with insulin resistance in White European men and women and in South Asian men, but the association weakened in South Asian women. The optimal cutpoints for detecting insulin resistance across those groups ranged from 2.0 to 3.8 in mg/dL. That is a wide spread, which underscores the problem with picking one number and declaring it the universal threshold.

Age adds another wrinkle. In younger adults (aged 20 to 50), women tend to have a noticeably lower ratio than men. But as people age past 65, the gap narrows and the ratios converge between the sexes. If you are an older adult comparing your ratio against cutoffs developed in younger populations, you may be judging yourself against the wrong standard.

Beyond Heart Disease and Insulin Resistance

Researchers have connected an elevated TG/HDL-C ratio to a growing list of conditions. The ratio’s usefulness as a screening shortcut extends well beyond cardiovascular risk.

Non-alcoholic fatty liver disease (NAFLD) shows one of the strongest associations. In a large cross-sectional study, people in the highest quarter of TG/HDL-C ratios had more than nine times the odds of having NAFLD compared to those in the lowest quarter, after adjusting for other factors. The optimal cutoff for detecting fatty liver was 0.9 in women and 1.4 in men (mmol/L units). In children already diagnosed with NAFLD, a higher ratio distinguished those with severe liver fat accumulation from those with milder forms, with a cutoff around 3.4 in mg/dL units.

Kidney health is another area of interest. In people with type 2 diabetes, a high ratio was linked to an increased risk of developing microvascular complications including retinopathy and chronic kidney disease, with the odds roughly doubling after adjusting for factors like diabetes duration and blood sugar control. A separate study of type 2 diabetic patients found that using a cutoff of 3.4, a high ratio was a strong marker for abnormal urinary albumin excretion, an early sign of kidney damage. In people without diabetes, the ratio still showed a moderate negative relationship with kidney function as measured by estimated filtration rate.

Using the Ratio in Children and Adolescents

Pediatric use of the TG/HDL-C ratio is gaining attention, particularly in screening overweight and obese kids for early metabolic trouble. In obese children and adolescents, a cutoff around 1.7 showed moderate ability to detect insulin resistance, with sensitivity above 71% but specificity around 55%. The study’s authors suggested the ratio works best as a supportive screening tool in primary care settings where directly measuring insulin is not practical.

In healthy (non-obese) children, the ratio has been evaluated for predicting metabolic syndrome predisposition. A cutoff of about 1.0 identified children at risk with roughly 74% sensitivity and 68% specificity, and children above that threshold were nearly six times more likely to show early signs of metabolic syndrome. Keep in mind that lipid levels shift during puberty, so a one-time reading in a 12-year-old should be interpreted cautiously and tracked over time rather than treated as a definitive verdict.

What Moves Your Ratio and How to Improve It

Because the ratio has two components, you can improve it by lowering triglycerides, raising HDL, or both. The interventions that do this best tend to overlap, which is convenient.

Dietary carbohydrate reduction is one of the most reliable levers. In a controlled trial comparing a very low carbohydrate diet to a low fat diet in normal-weight women, the low carb approach dropped triglycerides by about 30% while raising HDL by about 33%. LDL went up modestly, but the overall cholesterol-to-HDL ratio improved and post-meal triglyceride spikes fell sharply. You do not necessarily need to go very low carb; reducing refined carbohydrates and added sugars hits the same mechanisms less aggressively.

Exercise helps, but the benefit depends on your starting lipid profile. A large family-based study found that endurance exercise training raised HDL cholesterol significantly in men who started with high triglycerides and low HDL, by about 5%, with a simultaneous drop in triglycerides of about 15%. But in men who had low HDL without elevated triglycerides, exercise barely budged HDL at all. In other words, if your ratio is high because of elevated triglycerides, exercise is more likely to move it than if your HDL is simply genetically low.

On the pharmaceutical side, omega-3 fatty acid supplements and fenofibrate (a fibrate drug) both lower the ratio, though by different routes. In a head-to-head trial of patients with high triglycerides, omega-3s reduced triglycerides by about 21% and improved blood vessel function, while fenofibrate cut triglycerides by 29%, raised HDL, and additionally improved insulin sensitivity and adiponectin levels. Fenofibrate was more effective at lowering the TG/HDL-C ratio specifically when compared directly to omega-3 therapy. Statins, the most commonly prescribed cholesterol drugs, primarily target LDL and have smaller effects on the triglyceride-to-HDL dynamic, though they can modestly reduce triglycerides at higher doses.

The Alcohol Confound

If you drink alcohol regularly, your TG/HDL-C ratio may look misleadingly good. Alcohol raises HDL cholesterol, and light drinking in particular is associated with lower ratios. In a study of men with hypertension, light drinkers had about half the odds of having a high ratio compared to nondrinkers, and even heavy drinkers showed lower ratios than abstainers. This creates a real interpretive problem: a moderate drinker whose ratio sits at a comfortable 1.8 might actually have worse underlying insulin sensitivity than the number suggests, because alcohol is artificially inflating their HDL.

This does not mean alcohol is good for your metabolism. The HDL boost from drinking is a pharmacological effect that does not necessarily translate into the same cardiovascular protection as naturally high HDL. If you are tracking your ratio over time and your alcohol consumption changes, expect the number to shift for reasons unrelated to metabolic health.

Prediabetes and the Limits of Correlation

The ratio is clearly elevated in people with prediabetes compared to those with normal blood sugar. But whether it tracks tightly with the degree of insulin resistance within a prediabetic group is less certain. One study found that while the ratio was higher overall in prediabetic individuals, it did not actually correlate with their individual insulin resistance scores or with carotid artery thickness, a marker of early atherosclerosis. In a study of healthy Iraqi adults, a different cutoff of 3.1 distinguished insulin-resistant from insulin-sensitive individuals with about 83% sensitivity.

The gap between those two findings captures something important: the ratio is a screening shortcut, not a precision instrument. It is good at sorting people into broad risk groups, less reliable at telling you exactly how insulin resistant you are. Think of it as a metabolic smoke detector. A high ratio should prompt further investigation, such as fasting insulin, glucose tolerance testing, or advanced lipid profiling, but the ratio alone is not a diagnosis of anything.

Putting It All Together With Your Lab Results

When you pull up your next lipid panel, here is a practical way to use the ratio. Calculate it using whatever units your lab gives you. If you are in the United States and see mg/dL values, a ratio under 2.0 is generally reassuring. Between 2.0 and about 3.5, consider it a yellow flag worth discussing with your doctor, especially if you have other metabolic risk factors like abdominal obesity, elevated fasting glucose, or a family history of heart disease or diabetes. Above 3.5 to 4.0, the signal is strong enough to warrant investigation and likely intervention.

Adjust your expectations based on your sex. Women naturally run lower, so a ratio of 2.5 in a woman carries more relative risk than the same number in a man. If you are African American or South Asian, be aware that the standard cutoffs were mostly validated in White European populations and may not apply directly to you. The ratio still captures the right general metabolic signal, but the specific threshold where “normal” ends and “concerning” begins may differ from what a generic reference range suggests. Discussing the ratio alongside your other lab results, rather than interpreting it in isolation, is the best way to get actionable information from it.

The ratio also connects to adiposity measures beyond what shows up in bloodwork. In apparently healthy young men, the ratio tracked closely with BMI and body fat percentage, reinforcing its role as a broad metabolic indicator rather than a purely cardiovascular one. If you are working on weight loss or body composition changes, tracking your TG/HDL-C ratio over successive lab draws gives you an objective, inexpensive way to see whether your metabolic health is actually improving, even if the scale is not moving as fast as you would like.